New NPS MedicineWise educational program highlights medicine-related adverse events in older people

A new NPS MedicineWise health professional educational program launched today looks at the complex issues that contribute to the disproportionate number of medicine-related adverse events and hospital admissions experienced by older Australians.

NPS MedicineWise clinical adviser Dr Philippa Binns says the program will provide effective strategies to assist GPs manage polypharmacy and prevent medicine-related problems in patients aged 75 and over. 

“The proportion of older Australians aged 75 years or more taking multiple medicines is double that of those aged 50-64 years. Of course this reflects the increasing number and complexity of comorbidities that occur with age, but by taking more medicines older people also have a higher risk of adverse events,” says Dr Binns.

“Prescribing in older people is a balance between managing conditions according to disease based guidelines and addressing patient goals while at the same time avoiding medicine-related problems. Sometimes this may require medicines to be stopped.”

The new NPS MedicineWise educational program Older and wiser: promoting safe use of medicines in older people has launched today with the release of the September edition of Medicinewise News titled ‘Older, wiser, safer’.

The program and the new publication highlight the risks associated with medicines use in older people and provide strategies to help GPs manage these risks to ensure the benefits of medicines are realised. 

Importantly NPS MedicineWise is encouraging all prescribers, including general practitioners and specialists, to adopt a coordinated approach to medicines management as an important aspect of a care plan for an older person, and to engage older people, their family and carers as active partners in health decisions. 

“Medicines are an essential component of care in older people and medicines safety is best achieved in partnership with them, since they are the ones having to manage their health and medicines on a daily basis,” says Dr Binns. 

The September issue of Medicinewise News looks at how the highly individual and varied way older people age influences their health needs which in turn will define goals for treatment or prevention. It also examines the importance of documenting medicines management and follow up as part of the overall care plan for an older person.

“There’s not much that can be done to modify ageing-related physiological changes that make responses to medicines in older people less predictable, so it is essential to promptly detect and mitigate complications as they arise,” she says. 

“The new NPS MedicineWise educational program encourages prescribers to consider current medicines as the cause of new symptoms before looking elsewhere — don’t assume symptoms relate to old age.”

Dr Binns also explains that while some medicines increase the risk of adverse events, few adverse events are clearly preventable at the stage of prescribing, which highlights the importance of monitoring and follow-up.

“Often the only way to know if a symptom is a side effect of a medicine is to temporarily stop the medicine to see if the symptoms improve,” she says.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Short-duration psychedelic therapy shows promise for major depression treatment